SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-001861
Filing Date
2020-02-06
Accepted
2020-02-06 09:22:18
Documents
4
Period of Report
2020-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20200205_8k.htm 8-K 26683
2 EXHIBIT 10.1 ex_171553.htm EX-10.1 60461
3 EXHIBIT 10.2 ex_171554.htm EX-10.2 60685
4 logo.jpg GRAPHIC 9265
  Complete submission text file 0001437749-20-001861.txt   161919
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 20581452
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences